Skip to main content
PMC home page
Acta Pharmacologica Sinica logoLink to Acta Pharmacologica Sinica
. 2013 Aug 26;34(10):1337–1348. doi: 10.1038/aps.2013.86

Sensitive assay for measurement of volatile borneol, isoborneol, and the metabolite camphor in rat pharmacokinetic study of Borneolum (Bingpian) and Borneolum syntheticum (synthetic Bingpian)

Chen Cheng 1, Xin-wei Liu 1, Fei-fei Du 1, Mei-juan Li 1, Fang Xu 1, Feng-qing Wang 1, Yang Liu 1,$, Chuan Li 1,2,*, Yan Sun 1,*
PMCID: PMC4002161  PMID: 23974515

Abstract

Aim:

Both Borneolum (Chinese name Bingpian; dextrorotatory borneol) and Borneolum syntheticum (synthetic Bingpian; a mixture of optically inactive borneol and isoborneol) have been used for medicinal purposes in Chinese traditional medicine. The aim of this study was to develop a sensitive assay for measuring volatile ingredients borneol, isoborneol, and their metabolite camphor in pharmacokinetic study of Bingpian.

Methods:

Rat plasma samples were prepared using liquid-liquid microextraction: 70 μL of plasma sample (containing 125 nmol/L naphthalene as the internal standard) was extracted with 35 μL of n-hexane. The resulting n-hexane extract (20 μL) was introduced into a gas chromatography/mass spectrometry system using programmable temperature vaporizing-based large-volume injection. The assay was validated to demonstrate its reliability for the intended use. Using this assay, pharmacokinetic studies of Bingpian, synthetic Bingpian, and Fufang-Danshen tablets (containing synthetic Bingpian) were conducted in rats.

Results:

The extraction efficiency for the analytes and the internal standard from plasma was almost constant with decrease in n-hexane-to-plasma volume ratio, thus enabling a small volume of extracting solvent to be used for sample preparation, and enhancing the assay sensitivity. The lower quantification limit for measuring borneol, isoborneol, and camphor in plasma was 0.98 nmol/L, which was 33–330 times more sensitive than those reported earlier for Bingpian and synthetic Bingpian. The applicability of the miniaturized liquid-liquid extraction technique could be extended to measure other volatile and nonvolatile medicinal compounds in biomatrices, which can be predicted according to the analytes' octanol/water distribution coefficient (logD) and acid dissociation constant (pKa).

Conclusion:

This assay is sensitive, accurate and free of matrix effects, and can be applied to pharmacokinetic studies of Bingpian, synthetic Bingpian, and Bingpian-containing herbal products.

Keywords: pharmacokinetics, borneol, isoborneol, camphor, Bingpian, liquid-liquid microextraction, gas chromatography/mass spectrometry, large-volume injection

Introduction

Many important bioactive constituents of herbal medicines are volatile compounds1,2,3,4, which are commonly analyzed using hyphenated gas chromatography (GC) techniques5,6. To understand the contribution of these compounds to the medicinal effects of the herbal medicines containing them, it is important to investigate the pharmacokinetics and disposition of the volatile ingredients. However, associated pharmacokinetic (PK) studies are often hampered by assay failure in the measurement of such herbal compounds and their volatile metabolites in complex biomatrices. Liquid-liquid extraction is often used for GC-based analysis, which involves the transfer of volatile analytes from the aqueous biological sample into a water-immiscible organic solvent. Because of the column's low loading capacity (normally 1–2 μL), only a small portion of the organic extract is allowed to be introduced directly into the GC capillary column, which is unfavorable for the assay sensitivity. Conventional concentration of the organic extract under either reduced pressure or a stream of nitrogen gas can lead to serious evaporative losses of the volatile analytes and, in turn, result in unacceptable assay accuracy and the loss of sensitivity. To support trace analysis, Vogt developed a programmable temperature vaporizing (PTV) injector for large-volume injection (LVI) of an organic sample (up to 250 μL) in capillary GC, which involves a quick solvent vent technique7. Successful implementation of PTV-based LVI requires the use of an organic solvent that has a sufficiently lower boiling point (bp) than that of the analyte (typically >100 °C). Additionally, the solvent vapor needs to be minimized to avoid its substantial transfer to the vacuum system of the mass spectrometer. Furthermore, the solvent venting also needs to be stopped shortly before the completion of solvent evaporation because loss of the volatile analyte occurs primarily with the evaporation of the last few microliters of solvent8.

Borneolum (prepared from either Dryobalanops aromatica or Cinnamonum camphora) and Borneolum syntheticum (synthetically produced from turpentine oil) are used in Chinese traditional medicine under the name “Bingpian”9,10. Borneolum is dextrorotatory borneol (endo-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-ol) (Figure 1), which is a bicyclic monoterpene alcohol, whereas Borneolum syntheticum (also called synthetic Bingpian) is a mixture of optically inactive borneol and isoborneol (exo-1,7,7-trimethyl-bicyclo[2.2.1]heptan-2-ol). Bingpian and synthetic Bingpian exert medicinal actions, including restoring consciousness, removing heat, and relieving pain. Either Bingpian or synthetic Bingpian are commonly used as an ingredient in many Chinese combination herb therapies for treating cardiovascular and cerebrovascular diseases. Borneol and isoborneol have been reported to have a variety of in vitro pharmacological activities, including vasorelaxant11, anticoagulant12, neuroprotective13,14, sedative, and analgesic properties15,16. In addition, Bingpian and synthetic Bingpian have attracted much attention because of its possible enhancement of the oral bioavailability of other drugs and medicinal herbal compounds17,18, and the passage across the blood brain barrier19,20,21. Borneol can be oxidized to camphor (1,7,7-trimethylbicyclo[2.2.1]heptan-2-one), which has been observed in mice, rats, and rabbits receiving an oral dose of either Bingpian or synthetic Bingpian22. Camphor is believed to be poisonous when ingested in large quantities and can cause seizures, confusion, irritability, and neuromuscular hyperactivity23.

Figure 1.

Figure 1

Open in a new tab

Chemical structures of borneol, isoborneol, camphor, naphthalene, quercetin, ginkgolide A, orcinol glucoside, tanshinol, and cinnamic acid.

As part of our ongoing pharmacokinetic study of Fufang-Danshen-Fang24,25,26, a cardiovascular herb combination containing Salvia miltiorrhiza roots (Danshen), Panax notoginseng roots (Sanqi), and Bingpian, we developed a sensitive bioanalytical assay for the measurement of plasma concentrations of borneol, isoborneol, and their metabolite camphor. Several other assays have been reported for measurement of borneol and isoborneol in biomatrices using either GC-mass spectrometer27,28 or GC–flame ionization detector29,30,31,32,33. However, these assays lack sensitivity and/or accuracy for one of two reasons: 1) only a small portion of the organic sample extract was introduced into the GC capillary columns, or 2) the evaporative concentration of the organic extract was used for the sample clean-up. High sensitivity was achieved for our newly developed assay by using a liquid-liquid microextraction technique working in concert with an optimal PTV-based LVI of the organic extract, which led to significantly increased amounts of the analytes from the plasma sample being applied to GC-mass spectrometry-based analysis. To our knowledge, this is the first method of liquid-liquid microextraction combined with PTV-based LVI that has been developed for the measurement of plasma concentrations of volatile herbal compounds.

Materials and methods

Chemicals and materials

Analytical reference standards of (±)-borneol (bp 212–214 °C), (±)-isoborneol (212–214 °C), (±)-camphor (204 °C), naphthalene (218 °C), quercetin, ginkgolide A, tanshinol (sodiated form), and cinnamic acid were obtained from the National Institutes for Food and Drug Control (Beijing, China). Orcinol glucoside was kindly donated by Professor Jijun CHEN from Kunming Institute of Botany, the Chinese Academy of Sciences (Kunming, China). The purity of these compounds was greater than 98%. HPLC-grade organic solvents were obtained from Sinopharm Chemical Reagent Co, Ltd (Shanghai, China). HPLC-grade water was prepared with an in-house Millipore Milli-Q Integral 3 cabinet water purifying system (Bedford, MA, USA).

Bingpian (D. aromatica) and synthetic Bingpian for animal studies were obtained from Shanghai Huayu Chinese Herbs Co, Ltd (Shanghai, China). The Bingpian contained only borneol, which comprised 96.4% of the drug. The synthetic Bingpian contained both borneol and isoborneol, which comprised 62.1% and 37.6% of the drug, respectively. Fufang-Danshen tablets (Chinese SFDA ratification No Z31020478; Shanghai Leiyunshang Pharmaceutical Co, Ltd, Shanghai, China) contained Danshen, Sanqi, and synthetic Bingpian. The herbal tablets (0.32 g each) contained borneol (3.72 mg/tablet) and isoborneol (1.98 mg/tablet), which were standardized to contain ≥0.2 mg tanshinone IIA/tablet and ≥5.0 mg salvianolic acid B/tablet. Blank plasma was obtained from normal Sprague-Dawley rats receiving no drug treatment. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at the Shanghai Institute of Materia Medica (Shanghai, China).

GC-MS measurement of borneol, isoborneol, and camphor

A Trace GC Ultra Gas Chromatograph (Thermo Fisher Scientific, Milan, Italy) was coupled to a Trace DSQ II single quadrupole mass spectrometer (Thermo Fisher Scientific, Austin, TX, USA). Aliquots (20 μL) of n-hexane extract were introduced into a PTV injector with a glass sintered deactivated liner (Part No 45322060; ∼1.2 mm ID, 2.75 mm OD, 120 mm length, 135 μL theoretical volume) in the LVI mode at an injection temperature of 60 °C, an injection time of 0.2 min, a helium gas flow rate of 20 mL/min, a transfer heating rate of 14.5 °C/s, a transfer temperature of 280 °C, and a splitless time of 1 min. Subsequently, the cleaning temperature was increased to and maintained at 320 °C for 8 min at a helium gas flow rate of 300 mL/min to clean any remaining impurities. The chromatographic separation was achieved on a TR-5MS capillary column (30 m×0.25 mm ID; Thermo Fisher Scientific, Cheshire, UK) coated with 5% phenyl polysilphenylene-siloxane (0.25 μm film thickness), and the helium carrier gas (99.999% purity) was delivered at a rate of 1.5 mL/min. The following GC temperature program was used: 60 °C (0–2 min), 60 °C to 132 °C (2–11 min at 8 °C/min), 132 °C to 240 °C (11–12 min at 108 °C/min), 240 °C (12–14 min), and 240 °C to 60 °C (14–17 min at −60 °C/min). The mass spectrometry was operated in electron impact (EI) mode at 70 eV. The temperatures set for the transfer line and the ion source were identical, at 250 °C. Selected ion monitoring of borneol, isoborneol, camphor, and the internal standard naphthalene was achieved at m/z 95, 95, 95, and 128, respectively. Matrix-matched calibration curves were constructed for borneol, isoborneol, and camphor (0.25–16 000 nmol/L for each analyte) using weighted (1/X) linear regression of the analyte/internal standard peak area ratios (Y) against the corresponding nominal plasma concentrations of the analytes (X, nmol/L). The plasma concentration of the internal standard was 125 nmol/L.

Liquid-liquid microextraction for plasma sample clean-up

Thawed plasma samples (60 μL) were spiked with 10 μL of the internal standard solution and then extracted with 35 μL of n-hexane in glass tubes by vortex mixing at 1600 r/min for 3 min. After a short centrifugation, the supernatant organic extracts were aspirated into 100 μL glass inserts of a small internal diameter (placed in 1.5 mL polypropylene microcentrifuge tubes) and centrifuged at 21 000×g for 10 min. After centrifugation, the inserts were carefully placed in 2 mL sampler vials, and aliquots (20 μL) of the supernatants were used for GC-MS analysis.

Determination of analyte solubility

Borneol, isoborneol, camphor, and the internal standard naphthalene, as well as a variety of nonvolatile compounds (quercetin, ginkgolide A, orcinol glucoside, tanshinol, and cinnamic acid), were assessed for their solubility in phosphate buffered saline (PBS; pH 7.4) at 23 °C. In brief, a volume of 100 μL of PBS was added into a 10 mL glass centrifuge tube containing approximately 50 mg of solid test compound, and then the tube was sealed with parafilm. The suspension was sonicated for 10 min and vortexed at 1600 r/min for 5 min, which was repeated twice to enhance compound dissolution. After cooling to 23 °C, a small amount of the solid compound was added into the tube to promote precipitation. The resealed tube was kept under constant agitation and sampled at 24, 32, and 48 h. After centrifugation at 21 000×g for 10 min, the supernatant was diluted and measured by either GC–MS (for the volatile compounds) or LC-MS/MS (for the nonvolatile compounds). The compound solubility was established when equilibrium was achieved as determined by the constant concentrations measured with the two serial samples. A similar study was performed for the test compounds to assess their solubility in either n-hexane or ethyl acetate, except for tanshinol and cinnamic acid. The solubility of tanshinol in ethyl acetate was assessed by extracting the saturated aqueous solution of sodiated tanshinol with an equal volume of the organic solvent. The same procedure was performed to measure the solubility of cinnamic acid in ethyl acetate.

Assessment of the effects of the organic solvent-plasma volume ratio on the extraction efficiency and analyte response

Eighty microliters of rat plasma fortified with 200 nmol/L of borneol, isoborneol, camphor, or naphthalene were extracted in a glass tube with 20, 40, 80, 160, 320, or 640 μL of n-hexane to produce solvent-plasma volume ratios of 0.25, 0.5, 1, 2, 4, and 8, respectively. After vortex mixing and centrifugation, the n-hexane extract supernatant (2 μL) was used for GC-MS analysis. The extraction efficiency was determined by division of the analyte response (peak area) of the n-hexane extract versus that of the control n-hexane solution at the same compound concentration. A similar procedure was also performed using ethyl acetate as the extracting solvent for these volatile compounds, as well as the nonvolatile compounds ginkgolide A, quercetin, orcinol glucoside, tanshinol, and cinnamic acid. In addition, tanshinol and cinnamic acid were further tested individually using plasma samples acidified with 1 mol/L hydrochloric acid to adjust the pH to 1.2.

Assessment of matrix effects on GC-MS-based assay

The potential acute matrix-induced response enhancement34,35 was assessed using a post-extraction spike method36,37 for the PTV-based LVI involved in the GC-MS measurement of plasma levels of borneol, isoborneol, camphor, and the internal standard naphthalene. The matrix effects on the measurement of the analytes in plasma were examined by comparing the peak area of the test compounds between two different sample sets. In sample set 1, the test compounds were dissolved in matrix-free n-hexane and analyzed at concentrations of 3.91, 250, and 16000 nmol/L, except for the internal standard at 125 nmol/L. In sample set 2, blank rat plasma samples obtained from five rats were extracted with a half volume of n-hexane, and the resulting extracts were spiked with the analytes (3.91, 250, or 16000 nmol/L) and the internal standard (125 nmol/L). Division of the mean peak area of sample set 2 versus sample set 1 would indicate the possibility of an enhanced response (absolute matrix effect). When the absolute matrix effect was greater than 120%, additional variability of the peak area in sample set 2 versus that in sample set 1 would indicate the presence of a relative matrix effect.

A long-term study was implemented to assess the tolerance of the PTV injector and the GC capillary column with 100 successive injections (20 μL for each injection) of plasma extract standard containing borneol, isoborneol, camphor, and the internal standard naphthalene (250 nmol/L for each compound). The potential subchronic matrix effect was determined with regards to changes of the compound response (peak area), the column efficiency, the retention time, and the peak shape.

GC-MS-based assay validation

Assay validation was carried out according to the US FDA guidelines on bioanalytical method validation (http://www.fda.gov/cder/guidance/index.htm) to demonstrate that the newly developed bioanalytical method was reliable for its intended applications. The quality control samples were prepared from an independent weighing of the reference standards.

Application of assay to pharmacokinetic studies and blood sampling in rats

Male Sprague-Dawley rats (∼250 g) were obtained from the Sino-British SIPPR/BK Animal Laboratory (Shanghai, China). The use of rats and study protocols was approved by the IACUC (Shanghai, China). For blood sampling, a polyurethane cannula was cannulated aseptically into the femoral artery of each rat under pentobarbital anesthesia. After regaining their preoperative weights, the femoral artery-cannulated rats were randomly assigned to five groups (three rats/group) and received a single oral dose of Bingpian at 20 mg borneol/kg, synthetic Bingpian at 20 mg borneol+isoborneol/kg, or Fufang-Danshen tablet preparation at 20 mg borneol+isoborneol/kg or a single intravenous dose of Bingpian at 5 mg borneol/kg or synthetic Bingpian at 5 mg borneol+isoborneol/kg. For the oral administration, Bingpian, synthetic Bingpian, and Fufang-Danshen tablets were prepared separately by grounding and mixing them with 5% (w/v) Tween-80 to achieve concentrations of 1 mg borneol/mL, 1 mg borneol+isoborneol/mL, and 1 mg borneol+isoborneol/mL, respectively. For the intravenous administration, grounded Bingpian and synthetic Bingpian were dissolved in a mixture containing 0.5% (w/v) N,N-dimethylacetamide, 9.5% (w/v) cremophor EL, and 90% (v/v) saline to achieve a concentration of 1 mg borneol/mL and 1 mg borneol+isoborneol/mL, respectively. Serial blood samples (130–150 μL; 0, 5, 15, 30 min, and 1, 2, 4, 6, 8, 10, 14, and 24 h) were collected into heparinized tubes and centrifuged. The resulting plasma fractions were kept frozen at −70 °C until analysis. The plasma PK parameters were estimated using the non-compartmental model of the Kinetica 5.0 software (Thermo Fisher Scientific, Philadelphia, PA, USA).

Results

GC-MS-based measurement of borneol, isoborneol, and camphor and PTV-based LVI enhances assay sensitivity

In the EI-mass spectra (Figure 2), the molecular ions of borneol, isoborneol, and camphor (m/z 154, 154, and 152, respectively) are present at a low tendency. Accordingly, the most abundant fragment ions at m/z 95 were chosen for the sensitive measurement of these compounds. In contrast, the most intense ion of the internal standard naphthalene was its molecular ion at m/z 128 rather than the fragment ions. To facilitate refocusing of all the measured compounds at the top of the capillary column, the initial temperature of the column oven was set to 60 °C, which was 9 °C lower than the bp of n-hexane. This temperature was maintained for 2 min for complete splitless transfer and column equilibrium. As shown in Figure 2, the chromatographic peaks of borneol (tR, 9.22 min), isoborneol (9.05 min), camphor (8.75 min), and naphthalene (9.57 min) were completely separated from one another and shaped evenly under an optimal column oven heating rate of 8 °C/min.

Figure 2.

Figure 2

Open in a new tab

EI-MS spectra of borneol, isoborneol, camphor, and the internal standard naphthalene. The GC separation was achieved for these compounds.

To further increase assay sensitivity, PTV-based LVI (15–30 μL; using the ∼135-μL glass sintered deactivated liner) was optimized and compared with PTV-based splitless injection (2 μL) and PTV-based delayed splitless injection (5–15 μL). The important solvent split parameters for the PTV-based LVI were the injection temperature, the solvent split time, and the solvent split flow-rate; optimization was achieved on the basis of the separation of the solvent n-hexane from the most volatile compound camphor. In addition, the transfer heating rate, transfer temperature, and initial GC column temperature were also important because efficient transfer of the test compounds from the liner to the column was required after solvent elimination. As shown in Figure 3, the best result was obtained with the PTV-based LVI of 20 μL of a standard n-hexane solution containing borneol, isoborneol, camphor, and naphthalene. Increasing the injection size to 30 μL resulted in increased responses, but with considerable effects on the chromatographic peak shapes and vice versa. The unsuccessful implementation of PTV-based LVI over a volume of 20 μL was due to the insufficiently large differences in the bp between the measured compounds and the solvent n-hexane. However, a larger injection size (up to 50 μL) was successfully achieved when the more volatile solvent n-pentane (bp 36 °C) was used instead of n-hexane (69 °C). Although n-pentane was a more favorable solvent for PTV-based LVI, it was rejected for the sample preparation (due to excessively low viscosity) and for the GC-MS analysis with a long waiting time (due to excessively high volatility).

Figure 3.

Figure 3

Open in a new tab

Comparative GC-MS chromatograms for the simultaneous measurement of borneol (bp, 212–214 °C), isoborneol (212–214 °C), camphor (204 °C), and naphthalene (218 °C) in either n-hexane (69 °C) or n-pentane (36 °C) under different PTV modes with various injection volumes. The signal intensities (peak areas) of the test compounds increased significantly as the injection volume increased from 2 to 20 μL for n-hexane and from 2 to 50 μL for n-pentane, but the noise levels (measured at m/z 95 and m/z 128) did not change substantially.

Liquid-liquid microextraction enhances assay sensitivity

Although n-hexane is an efficient solvent for extraction of borneol, isoborneol, camphor, and the internal standard naphthalene, evaporative losses of these volatile compounds when extracting from plasma occur upon the subsequent dry-down step. For traditional liquid-liquid extraction, the extracting solvent is often used in a solvent-to-sample volume ratio ranging from 3 to 10. The use of a large volume of extracting solvent is supposed to enhance the extraction efficiency. However, excessive solvent levels in this extraction method have a considerable dilution effect, i.e., the analyte concentration in the organic extract is lower than that in the pre-extracted aqueous sample. The application of such an organic extract (without any evaporative reduction) to GC-based analysis will result in decreased assay sensitivity. In the current study, we investigated the effect of the organic solvent-to-plasma volume ratio on the liquid-liquid extraction efficiency. As shown in Figure 4A, the extraction recoveries of borneol, isoborneol, camphor, and naphthalene from plasma using n-hexane as the solvent were almost constant with the decreasing n-hexane-to-plasma volume ratio. This consistency enabled the use of a small volume of extracting solvent for sample preparation to enhance the assay sensitivity by counteracting the aforementioned dilution effect, which was referred to as “liquid-liquid microextraction”. For ease of operation, a small n-hexane-to-plasma volume ratio of 0.5 was chosen for preparation of the plasma samples (70 μL) to ensure an enriched level of test compounds in the organic phase. Aside from the enhancement of assay sensitivity, this newly developed liquid-liquid microextraction method had other advantages, including organic solvent economy, environmental friendliness, and improved assay throughput.

Figure 4.

Figure 4

Open in a new tab

Correlations between the organic solvent-plasma volume ratio (▵ or ▴) and extraction efficiency (○ or •) for various compounds. The nonvolatile compounds quercetin, ginkgolide A, orcinol glucoside, tanshinol, and cinnamic acid were measured by LC-MS/MS. Chromatographic separation was achieved using a Phenomenex Gemini 5 μm C18 column (50×2.0 mm id; Torrance, CA, USA). The water/acetonitrile/formic acid-based mobile phases were delivered at 0.3 mL/min for a binary pulse gradient elution41. The precursor-to-product ion pairs m/z 407→351, 301→151, 331→123, 197→135, and 147→103 in the negative ESI ion mode were used for selected reaction monitoring of ginkgolide A, quercetin, orcinol glucoside, tanshinol, and cinnamic acid, respectively.

To extend the application of the liquid-liquid microextraction method, ethyl acetate was also tested as a solvent for recovering borneol, isoborneol, camphor, and naphthalene from plasma. The results suggested that the performance of ethyl acetate for the compound extraction was similar to that of n-hexane. Although the relatively high bp (77 °C) is unfavorable for the PTV-based LVI used in the current study, ethyl acetate is commonly used in sample preparation for many nonvolatile compounds. Figure 4B shows the results of the ethyl acetate-based liquid-liquid extraction of several nonvolatile medicinal herbal compounds from plasma. The extraction efficiency was high for quercetin and ginkgolide A in an ethyl acetate-to-plasma volume ratio-independent manner. However, the extraction of orchinol glucoside, tanshinol, and cinnamic acid was significantly dependent on the ethyl acetate volume used; thus a large volume of the solvent was needed for high extraction recovery. The observed inconsistency in extraction performance appeared to be related to the organic solvent-to-water solubility ratios (SO/SW ratios) of the test compounds (Table 1). When the pH value of the aqueous phase was 7.4, the measured solubility ratios of borneol, isoborneol, camphor, naphthalene, quercetin, and ginkgolide A were high (122–9435; using n-hexane or ethyl acetate as the organic solvent), but those of orchinol glucoside, tanshinol, and cinnamic acid were very low (0.0006–0.137; using ethyl acetate as the organic solvent). These results could be predicted because the calculated logD values (pH 7) of the compounds were well correlated with their measured solubility ratios (Table 1). The logD values (pH 7) of borneol, isoborneol, camphor, naphthalene, quercetin, and ginkgolide A ranged from −0.14 to 3.36, which were greater than those of orchinol glucoside, tanshinol, and cinnamic acid (−4.73 to −0.28), with a logD value of >–0.2 serving as the threshold. Tanshinol and cinnamic acid are weak acids with low ionization constants (pKa) of 3.3 and 4.5, respectively. Liquid-liquid extraction efficiency is significantly affected by the existing state of the test compound in the aqueous phase because the compound in either its ionized form or molecular form favors the aqueous phase or the organic phase, respectively. Accordingly, plasma samples that were spiked with either tanshinol or cinnamic acid were acidified with 1 mol/L hydrochloric acid to a pH of 1.2. The acidification resulted in increased ethyl acetate-based extraction efficiency for cinnamic acid but not for tanshinol (Figure 4C). As shown in Table 1, the effect of acidification on the enhanced extraction efficiency appeared to be predictable by comparing the logD values (pH 7 and pH 1) of the compounds. The logD values (pH 7 and pH 1) of cinnamic acid were −0.38 to −1.77 and 1.21 to 2.16, respectively, whereas those of tanshinol were −3.77 to −4.73 and −0.28 to −1.15, respectively.

Table 1. Physicochemical properties of borneol, isoborneol, camphor, and naphthalene, as well as those of quercetin, ginkgolide A, orcinol glucoside, tanshinol, and cinnamic acid.

Compound
 Measured solubility (mg/mL)
 SW/SO
 pKa1
 LogD by ACD
 LogD by Pallas
  SW SO     pH=1 pH=7 pH=1 pH=7
Organic solvent: n-hexane
Borneol 0.71 87 122 >14 2.55 2.55 3.00 3.00
Isoborneol 0.69 88 127 >14 2.55 2.55 3.00 3.00
Camphor 1.84 347 189 >14 2.09 2.09 2.92 2.92
Naphthalene 0.023 171 7435 >14 3.36 3.36 3.12 3.12
Organic solvent: ethyl acetate
Borneol 0.71 315 444 – – – – –
Isoborneol 0.69 513 743 – – – – –
Camphor 1.84 698 379 – – – – –
Naphthalene 0.023 217 9435 – – – – –
Quercetin 0.007 17 2414 8.8 1.99 1.99 1.85 1.84
Ginkgolide A 0.22 53.0 241 11.3 −0.04 −0.04 −0.14 −0.14
Orcinol glucoside 342 5.0 0.01 9.8 −0.9 −0.9 −0.75 −0.75
Tanshinol 297 0.019 0.00006 3.3 −1.15 −4.73 −0.28 −3.77
Cinnamic acid 25.2 3.46 0.137 4.5 1.21 −1.77 2.16 −0.38
Open in a new tab

SW, water solubility at pH 7.4. SO, solubility in the organic solvent n-hexane or ethyl acetate. pKa1 and LogD values were calculated using ACD/aqueous solubility v8.02 via the ACD/I-Lab service (Advanced Chemistry Development Inc, Toronto, Canada). LogD was also calculated using Pallas software (Pallas 3.7.1.1; CompuDrug International, Sedona, AZ, USA).

Assay reliability and sensitivity

The potential acute matrix-induced response enhancement was assessed during assay development. As a result, the matrix components from the n-hexane-extracted plasma samples had a negligible influence on the measurement of borneol, isoborneol, camphor, and the internal standard naphthalene, demonstrating absolute matrix effects of 91.5%–104%, 93.3%–109%, 89.6%–107%, and 103%, respectively. Accordingly, calculation of the relative matrix effects was unnecessary. As shown in Table 2, the compound responses and the chromatographic behaviors (eg, column efficiency, retention times, and peak shapes) did not change significantly during and after 100 successive injections of the plasma extract standard, indicating good tolerance of the PTV injector and the GC column for long-term use with biomatrix samples.

Table 2. Long-term stability of the measurement of the plasma extract standard containing borneol, isoborneol, camphor, and the internal standard naphthalene (250 nmol/L for each compound). The data are expressed as the mean±standard deviation (relative standard deviation).

Compound
 Response (×104)
 Chromatographic parameters
    Column efficiency (×104) Retention time (min) Asymmetry factor
Injection Nos: 1–30
Borneol 130±6 (4.6%) 19.5±2.4 (12.3%) 9.18±0.01 (0.1%) 1.00±0.13 (12.7%)
Isoborneol 88±6 (6.8%) 20.4±2.5 (12.3%) 9.02±0.01 (0.1%) 1.02±0.08 (7.4%)
Camphor 50±3 (6.0%) 24.1±2.5 (10.4%) 8.72±0.01 (0.1%) 0.97±0.11 (11.7%)
Naphthalene 142±7 (4.9%) 12.2±1.5 (12.3%) 9.52±0.01 (0.1%) 1.30±0.19 (14.7%)
Injection Nos: 31–60
Borneol 130±10 (7.7%) 21.0±2.1 (10.0%) 9.21±0.01 (0.1%) 0.98±0.08 (8.4%)
Isoborneol 85±7 (8.2%) 20.9±2.0 (9.6%) 9.04±0.01 (0.1%) 1.04±0.07 (6.5%)
Camphor 49±3 (6.1%) 23.1±3.1 (13.4%) 8.74±0.01 (0.1%) 1.02±0.10 (9.8%)
Naphthalene 140±12 (8.6%) 13.0±1.7 (13.1%) 9.54±0.01 (0.1%) 1.22±0.15 (11.9%)
Injection Nos: 61–100
Borneol 137±8 (5.8%) 21.8±2.6 (12.0%) 9.21±0.01 (0.1%) 0.96±0.13 (13.5%)
Isoborneol 90±6 (6.7%) 20.5±2.6 (12.7%) 9.05±0.01 (0.1%) 0.97±0.09 (9.4%)
Camphor 49±4 (8.2%) 23.0±3.0 (13.0%) 8.75±0.01 (0.1%) 0.96±0.12 (12.1%)
Naphthalene 140±11 (7.9%) 12.2±1.7 (13.9%) 9.55±0.01 (0.1%) 1.19±0.16 (13.3%)
Open in a new tab

Number of theoretic plates=5.54×(retention time÷peak width at 1/2 height)2. Peak asymmetry factor was defined as the distance from the center line of the peak to the back slope divided by the distance from the center line of the peak to the front slope, with all measurements made at 10% of the maximum peak height.

The analytes borneol, isoborneol, camphor, and the internal standard naphthalene were stable under analytical conditions mimicking those experienced by real plasma samples during an assay run. The calibration curves for the measurement of the analytes exhibited good linear ranges from 0.98 to 16000 nmol/L with correlation coefficients >0.99. As shown in Table 3, the within-run (n=5) and between-run (n=3) assay precision, assessed at the nominal plasma concentrations 0.98, 250, and 16 000 nmol/L, were reliable (4.5%–9.6% for borneol, 5.9%–9.0% for isoborneol, and 3.1%–7.2% for camphor), and the associated assay accuracies were also satisfactory (90.0%–111% for borneol, 94.0%–109% for isoborneol, and 98.5%–113% for camphor). Accordingly, the lower quantification limit of 0.98 nmol/L was acceptable for the measurement of borneol, isoborneol, and camphor in plasma. To the best of our knowledge, the sensitivity of our newly developed assay is notably higher than that reported for the measurement of the monoterpene alcohols in plasma (32.5–325 nmol/L)27,28,29,30,31,32,33.

Table 3. Assay accuracy and precision (relative standard deviation) for the measurement of borneol, isoborneol, and camphor in rat plasma. The data are expressed as the mean±standard deviation (relative standard deviation).

Nominal concentration (nmol/L)
 Within-run (n=5)
 Between-run (n=3)
  Measured concentration (nmol/L) Accuracy (%) Measured concentration (nmol/L) Accuracy (%)
Borneol
0.98 0.88±0.08 (9.6%) 90 0.97±0.13 (13.4%) 99
250 270±17.8 (6.6%) 108 264±13 (4.9%) 106
16000 17760±799 (4.5%) 111 16983±1036 (6.1%) 106
Isoborneol
0.98 1.07±0.07 (6.5%) 109 1.04±0.06 (5.6%) 106
250 235±13.9 (5.9%) 94 248±17 (7.0%) 99
16000 16800±1512 (9.0%) 105 16736±1088 (6.5%) 105
Camphor
0.98 0.97±0.07 (7.2%) 99 0.10±0.07 (6.6%) 105
250 246±8.86 (3.6%) 99 250±11 (4.5%) 100
16000 18080±560 (3.1%) 113 16114±1337 (8.3%) 101
Open in a new tab

Application of the novel assay in the pharmacokinetic study of Bingpian, synthetic Bingpian, and Fufang-Danshen tablets

The pharmacokinetic study of Bingpian, synthetic Bingpian, and the synthetic Bingpian-containing phytopharmaceutical product Fufang-Danshen tablets in rats is an ideal application of the newly developed assay. Figure 5 depicts the plasma level-time profiles of borneol, isoborneol, and their metabolite camphor; the associated plasma pharmacokinetic parameters are summarized in Table 4. The oral bioavailability (F) of borneol was low (8.3%–14.5% for Bingpian, 11.9%–14.0% for synthetic Bingpian, and 10.9%–17.8% for the Fufang-Danshen tablets). The F values of isoborneol were also low (2.0%–4.9% for synthetic Bingpian and 4.8%–12.7% for the Fufang-Danshen tablets). The metabolism from borneol and isoborneol to camphor appeared to contribute to the first-pass elimination of the monoterpene alcohols. This was indicative of the mean ratio of “camphor”-to-“borneol+isoborneol” in AUC0–∞ (0.72) after oral administration of synthetic Bingpian was greater than the ratio (0.29) after intravenous administration of the same drug. The mean ratio of “camphor”-to-“borneol” after oral ingestion of Bingpian was approximately 4 times greater than the ratio after intravenous administration of Bingpian. The plasma concentrations of borneol after the intravenous dose of either Bingpian or synthetic Bingpian declined in a biphasic fashion with first mean half-lives (t1/2–(1)) of 0.7–0.8 h and second mean half-lives (t1/2–(2)) of 8.0–8.5 h, and the plasma concentrations of isoborneol declined rapidly (t1/2–(1), 1.0–1.3 h). The mean total plasma clearance (CLtot,p) values of borneol were 12.3 L·h−1·kg−1 (for Bingpian) and 8.6 L·h−1·kg−1 (for synthetic Bingpian) and the mean CLtot,p of isoborneol was 13.7 L·h−1·kg−1 (for synthetic Bingpian). The mean distribution volumes at steady state (VSS) of borneol (40.2 and 50.7 L/kg for Bingpian and synthetic Bingpian, respectively) and isoborneol (13.0 L/kg for synthetic Bingpian) exceeded the reported volume of rat total body water (0.67 L/kg)38, suggesting that borneol and isoborneol tended to bind to the tissue components. Borneol was not transformed to isoborneol in rats, which was indicated by the lack of isoborneol detected in plasma after the administration of Bingpian.

Figure 5.

Figure 5

Open in a new tab

Rat plasma concentration-time profiles of borneol, isoborneol, and their metabolite camphor after an oral dose of Bingpian (20 mg borneol/kg), synthetic Bingpian (20 mg borneol+isoborneol/kg), or Fufang-Danshen tablets (containing synthetic Bingpian; 20 mg borneol+isoborneol/kg) or an intravenous dose of Bingpian (5 mg borneol/kg) or synthetic Bingpian (5 mg borneol+isoborneol/kg).

Table 4. Plasma pharmacokinetics of borneol, isoborneol, and camphor in rats receiving Bingpian, synthetic Bingpian, or Fufang-Danshen tablets. The data are expressed as the mean±standard deviation (relative standard deviation).

Compound Cmax or C5 min (nmol/L) Tpeak (h) AUC0–t (h·nmol/L) AUC0–∞ (h·nmol/L) (h) t1/2–(1) (h) t1/2–(2) (h) MRT (h) CLtot, p (L·h−1·kg−1) VSS (L/kg) F (%)
Natural Bingpian at an oral dose of 20 mg borneol/kg
Borneol 116±39 0.083±0 1266±307 1558±413 – – 10.6±0.8 – – 11.6±2.8
Camphor 108±50 0.083±0 362±24 432±106 – – 6.1±1.8 – – –
Natural Bingpian at an intravenous dose of 5 mg borneol/kg
Borneol 5122±1030 – 2724±517 2825±583 0.7±0.1 8.5±2.0 2.5±0.8 12.3±2.5 40.2±12.0 –
Camphor 149±17 – 207±77 210±78 1.3±0.5 – 1.6±0.5 – – –
Synthetic Bingpian at an oral dose of 20 mg borneol+isoborneol/kg
Borneol 201±114 0.083±0 1209±105 1726±354 – – 11.3±0.3 – – 12.7±1.1
Isoborneol 84±34 0.39±0.53 310±140 331±135 – – 10.4±3.0 – – 8.7±3.9
Camphor 354±15 0.14±0.10 1311±461 1471±547 – – 8.8±1.2 – – –
Synthetic Bingpian at an intravenous dose of 5 mg borneol+isoborneol/kg
Borneol 3691±374 – 2375±230 2576±265 0.8±0.1 8.0±2.9 3.6±0.7 8.6±0.9 50.7±16.9 –
Isoborneol 2113±141 – 893±83 902±74 1.0±0.1 – 0.9±0.2 13.7±1.4 13.0±1.3 –
Camphor 349±24 – 984±172 1011±161 2.5±3.1 – 4.1±0.7 – – –
Fufang-danshen tablets at an oral dose of 20 mg borneol+isoborneol/kg
Borneol 109±24 1.39±2.26 1349±327 1612±262 – – 12.0±1.2 – – 14.2±3.4
Isoborneol 35±21 1.39±2.26 101±64 105±71 – – 5.3±2.4 – – 2.8±1.8
Camphor 201±160 2.69±2.26 1128±297 1456±589 – – 7.8±1.2 – – –
Open in a new tab

Cmax, maximum plasma concentration after oral dose; C5 min, plasma concentration at 5 min after intravenous dose; Tpeak, time taken to achieve peak concentration; t1/2, elimination half-life; AUC0←t, area under concentration-time curve up to the time of last measurable concentration; AUC0←∞, AUC0←t extrapolated to infinity; MRT, mean residence time; CLtot,p, total plasma clearance; VSS, distribution volume at steady state.

Discussion

The use of herbal therapies is escalating worldwide. In correlating the administration of herbal medicines with their beneficial effects, it is important to understand the absorption, disposition, and pharmacokinetics of their active ingredients after dosing. In addition to nonvolatile ingredients, many volatile constituents are also pharmacologically important for herbal therapies. However, the assays available for measuring volatile compounds have not been very successful in supporting the associated pharmacokinetic studies. Herein, we developed a reliable assay for the sensitive measurement of borneol, isoborneol, and their metabolite camphor in plasma to support a pharmacokinetic study of Bingpian. The high sensitivity of this assay was achieved by using a liquid-liquid microextraction technique in concert with PTV-based LVI of the organic extract for GC-MS, which was 33–330 times higher than the sensitivity of earlier reported analytical methods for Bingpian27,28,29,30,31,32,33. To our knowledge, this is the first time that liquid-liquid microextraction has been combined with PTV-based LVI and developed to measure the concentrations of volatile herbal compounds in complex biomatrices. Our study provides a simple, effective solution to the analytical problem hampering the implementation of pharmacokinetic studies of herbal medicines containing volatile ingredients of pharmacological importance.

Several liquid-liquid microextraction techniques such as single-drop microextraction, hollow fiber liquid phase microextraction, and dispersive liquid-liquid microextraction have been developed39. However, these techniques have some disadvantages, including tedious and labor-consuming operation, the requirement of special equipment, and applicability to a limited range of analytes. Recently, Serrano et al developed a similar liquid-liquid microextraction combined with PTV-based LVI for water analysis to measure haloacetaldehyde concentrations in swimming pool water40. In this current study, the developed method of liquid-liquid microextraction combined with PTV-based LVI is quite feasible and can be routinely used for pharmacokinetic studies of Bingpian and the associated herbal products. The utilization ratio of the injection volume (20 μL) to the extracting solvent volume (35 μL) was high (57%). Our work is an important addition to previous studies associated with miniaturized liquid-liquid extraction techniques because we have addressed the application of this technique in the analysis of volatile and nonvolatile compounds, which could be predicted according to the analytes' logD and pKa. Compounds with logD>−0.2 appeared to be more suitable for such liquid-liquid microextraction.

Acute matrix-induced response enhancement has been observed for GC-based analyses of pesticide residues in fatty foods34,35. The matrix protects the analytes from both adsorption and alterations during transfer from the injector (especially in the injection liner) to the capillary column. The matrix effect results in the response of the analyte from a matrix sample being higher than that from a matrix-free solution containing the compound at the same concentration. In this study, the acute matrix-induced response enhancement was almost negligible for the measurement of plasma concentrations of borneol, isoborneol, camphor, and the internal standard naphthalene. In addition, the compound responses and the chromatographic behaviors did not change significantly during and after 100 successive injections of the plasma extract standard, indicating good tolerance of the PTV injector and the GC column for long-term use with plasma samples. It has been reported that polar compounds (containing phosphate, hydroxyl, amino, imidazole, benzimidazole, carbamate, and urea functional groups), as well as strong acids and/or bases, are more susceptible to matrix-induced enhancement35. Borneol, isoborneol, camphor, and naphthalene are nonpolar and neutral compounds, which might explain the observed negligible matrix effects on the GC-MS-based measurement of the analytes.

In summary, a reliable GC-MS-based assay for the sensitive measurement of plasma concentrations of borneol, isoborneol, and their metabolite camphor was developed, primarily by using liquid-liquid microextraction in concert with PTV-based LVI of the organic extract. The application of the miniaturized liquid-liquid extraction technique could be extended to the measurement of other volatile compounds and many nonvolatile medicinal compounds in biomatrices, which can be predicted according to the logD and pKa of the analytes. On the basis of this newly developed assay, it was observed that, in rats, isoborneol was more likely to be metabolized into camphor than borneol.

Author contribution

Chuan LI, Chen CHENG, and Yan SUN designed the research; Chen CHENG, Xin-wei LIU, Fei-fei DU, Mei-juan LI, Fang XU, Feng-qing WANG, and Yang LIU, performed the research; Chuan LI, Chen CHENG, Xin-wei LIU, and Yan SUN analyzed data; Chuan LI and Chen CHENG wrote the paper.

Acknowledgments

This study was financially supported by the National Natural Science Fundation of China for Distinguished Young Scholars (Grant 30925044), the National Basic Research Program of China (Grant 2012CB518403), and the National Science and Technology Major Project of China “Key New Drug Creation and Manufacturing Program” (Grant 2009ZX09304-002).

References

  1. Aoshima H, Hamamoto K. Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosci Biotechnol Biochem. 1999;63:743–8. doi: 10.1271/bbb.63.743. [DOI] [PubMed] [Google Scholar]
  2. Mühlbauer RC, Lozano A, Palacio S, Reinli A, Felix R. Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone. 2003;32:372–80. doi: 10.1016/s8756-3282(03)00027-9. [DOI] [PubMed] [Google Scholar]
  3. Huang LS, Gu YF, Li H.Advances in herbal volatile oil and aromatic herbs China J Chin Mater Med 2009341606–11.Chinese. [PubMed] [Google Scholar]
  4. Miguel MG. Antioxidant and anti-inflammatory activities of essential oils: a short review. Molecules. 2010;15:9252–87. doi: 10.3390/molecules15129252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Liang YZ, Xie PS, Chan K. Quality control of herbal medicines. J Chromatogr B. 2004;812:53–70. doi: 10.1016/j.jchromb.2004.08.041. [DOI] [PubMed] [Google Scholar]
  6. Li P, Qi LW, Liu EH, Zhou JL, Wen XD. Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models. Trends Anal Chem. 2008;27:66–77. [Google Scholar]
  7. Vogt W, Jacob K, Ohnesorge AB, Obwexer HW. Capillary gas chromatographic injection system for large sample volumes. J Chromatogr. 1979;186:197–205. [Google Scholar]
  8. Ŝtajnbaher D, Zupančič-Kralj L. Optimization of programmable temperature vaporizer-based large volume injection for determination of pesticide residues in fruits and vegetables using gas chromatography-mass spectrometry. J Chromatogr A. 2008;1190:316–26. doi: 10.1016/j.chroma.2008.03.002. [DOI] [PubMed] [Google Scholar]
  9. “Zhonghua Bencao” Commission of State Administration of Traditional Chinese Medicine of the People's Republic of China. Zhonghua Bencao (Encyclopedia of Chinese Materia Medica); book 3. Shanghai: Shanghai Scientific and Technical Publishers; 1999. p 551–5 (natural Bingpian).
  10. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (English Edition 2010); v 1. Beijing: China Medical Science Press; 2010. p 73–4 (natural Bingpian), 72–3 (synthetic Bingpian), and 684–6 (Fufang-danshen tablets).
  11. Silva-Filho JC, Oliveira NNPM, Arcanjo DDR, Quitans-Júnior LJ, Cavalcanti SCH, Santos MRV, et al. Investigation of mechanisms involved in (−)-borneol-induced vasorelaxant response on rat thoracic aorta. Basic Clin Pharmacol Toxicol. 2011;110:171–7. doi: 10.1111/j.1742-7843.2011.00784.x. [DOI] [PubMed] [Google Scholar]
  12. Li YH, Sun XP, Zhang YQ, Wang NS. The antithrombotic effect of borneol related to its anticoagulant property. Am J Chin Med. 2008;36:719–27. doi: 10.1142/S0192415X08006181. [DOI] [PubMed] [Google Scholar]
  13. Tian LL, Zhou Z, Zhang Q, Sun YN, Li CR, Cheng CH, et al. Protective effect of (±)isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells. Cell Physiol Biochem. 2007;20:1019–32. doi: 10.1159/000110682. [DOI] [PubMed] [Google Scholar]
  14. Liu R, Zhang L, Lan X, Li L, Zhang TT, Sun JH, et al. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor ĸappaB signaling pathway. Neuroscience. 2011;176:408–19. doi: 10.1016/j.neuroscience.2010.11.029. [DOI] [PubMed] [Google Scholar]
  15. Park TJ, Park YS, Lee TG, Ha HJ, Kim KT. Inhibition of acetylcholine-mediated effects by borneol. Biochem Pharmacol. 2003;65:83–90. doi: 10.1016/s0006-2952(02)01444-2. [DOI] [PubMed] [Google Scholar]
  16. Granger RE, Campbell EL, Johnston GAR. (+)- and (−)-borneol: efficacious positive modulator of GABA action at human recombinant α1β2γ2L GABAA receptors. Biochem Pharmacol. 2005;69:1101–11. doi: 10.1016/j.bcp.2005.01.002. [DOI] [PubMed] [Google Scholar]
  17. Chen TF, Lin SG, Chen LX, Jiang GF, Liang ZY, Yang M, et al. Enhancement of absorption of tetramethylpyrazine by synthetic borneol. Acta Pharmacol Sin. 1990;11:42–4. [PubMed] [Google Scholar]
  18. Cheng G, Wu SR, Feng Y.Studies on the effects of borneol on the pharmacokinetics of rifampicin J Shenyang Pharm Univ 200118398–401.Chinese. [Google Scholar]
  19. Liu QD, Liang MR, Chen ZX, Feng MR, Zhao P.The influence of borneol on the passing of gentamycin through blood-brain barrier J Guangzhou College Tradit Chin Med 19941137–40.Chinese. [Google Scholar]
  20. Dong XZ, Tang XA, Qiu QH, Xu HB.Study on the auto-action of borneol assisting the penetration of DDP across BBB Chin Pharm J 200237275–7.Chinese. [Google Scholar]
  21. Cai Z, Hou SX, Li YB, Zhao BB, Yang ZX, Xu SG, et al. Effect of borneol on the distribution of gastrodin to the brain in mice via oral administration. J Drug Target. 2008;16:178–84. doi: 10.1080/10611860701794395. [DOI] [PubMed] [Google Scholar]
  22. Jiang XF, Zou JL, Yuan YM, Law FCP, Qiao YJ, Yao MC. Preliminary study: biotransformation of borneol to camphor in mice, rats and rabbits. Mode Tradit Chin Med Mater Med. 2008;10:27–36. [Google Scholar]
  23. Manoguerra AS, Erdman AR, Wax PM, Nelson LS, Caravati EM, Cobaugh DJ, et al. Camphor poisoning: an evidence-based practice guideline for out-of-hospital management. Clin Toxicol. 2006;44:357–70. doi: 10.1080/15563650600671696. [DOI] [PubMed] [Google Scholar]
  24. Lu T, Yang JY, Gao XM, Chen P, Du FF, Sun Y, et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos. 2008;36:1578–86. doi: 10.1124/dmd.108.021592. [DOI] [PubMed] [Google Scholar]
  25. Liu HF, Yang JL, Du FF, Gao XM, Ma XT, Huang YH, et al. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab Dispos. 2009;37:2290–8. doi: 10.1124/dmd.109.029819. [DOI] [PubMed] [Google Scholar]
  26. Hu ZY, Yang JL, Cheng C, Huang YH, Du FF, Wang FQ, et al. Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi) Drug Metab Dispos. 2013;41:1457–69. doi: 10.1124/dmd.113.051391. [DOI] [PubMed] [Google Scholar]
  27. Chen Q, Li SM, Wang W.GC-MS simultaneous determination of borneol and paeonol in mice plasma Chin J Pharm Anal 200626592–4.Chinese. [Google Scholar]
  28. Huang TL, Ye SM, Ou WP, Mi SQ.Comparative study of the pharmacokinetics of borneolum syntheticum and borneol in herbal preparations Tradit Chin Drug Res Clin Pharmacol 200617265–7.Chinese. [Google Scholar]
  29. Guo J, Huang X, Wang LL, Meng H, Zhang L, Ren P.Synchro-determination of borneol and tetramethyl pyrazine in plasma by GC-FID for volunteers administered with Suxiao Jiuxin Wan Chin Tradit Herb Drugs 200334730–2.Chinese. [Google Scholar]
  30. Song HT, Guo T, Zhang XH, Kang J, Leng YX, Zhang RH.Determination of borneol in human plasma by capillary gas chromatography Pharm J Chin PLA 20031912–5.Chinese. [Google Scholar]
  31. Xiao YY, Ping QN, Chen ZP. A simple gas chromatographic method for the simultaneous determination and pharmacokinetic study of tetramethylpyrazine phosphate and borneol in mouse plasma and brain tissue after oral administration of the Fufang tetramethylpyrazine phosphate tablets. J Chromatogr Sci. 2008;46:395–400. doi: 10.1093/chromsci/46.5.395. [DOI] [PubMed] [Google Scholar]
  32. Xu XF, Li YB, Hou JP, Zhang SZ, Xu YY, Wang Y, et al. Pharmacokinetic study of borneol and menthol in rats after oral administration of qingyan drop pills. Planta Med. 2011;77:1600–4. doi: 10.1055/s-0030-1270998. [DOI] [PubMed] [Google Scholar]
  33. Zhao JY, Lu Y, Du SY, Song X, Bai J, Wang Y.Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations J Zhejiang Univ-Sci B (Biomed & Biotechnol) 201213990–6.Chinese. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Erney DR, Gillespie AM, Gilvydis DM. Explanation of the matrix-induced chromatographyic response enhancement of organophosphorus pesticides during open tubular column gas chromatography with splitless or hot on-column injection and flame photometric detection. J Chromatogr A. 1993;638:57–63. [Google Scholar]
  35. Poole CF. Matrix-induced response enhancement in pesticide residue analysis by gas chromatography. J Chromatogr A. 2007;1158:241–50. doi: 10.1016/j.chroma.2007.01.018. [DOI] [PubMed] [Google Scholar]
  36. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75:3019–30. doi: 10.1021/ac020361s. [DOI] [PubMed] [Google Scholar]
  37. Guo B, Li C, Deng ZP, Chen SX, Ji ZH, Zhang JW, et al. A new method for measurement of (−)-sophocarpine, a candidate therapeutic for viral myocarditis, in plasma: application to a toxicokinetic study in beagle dogs. Rapid Commun Mass Spectrom. 2005;19:2840–8. doi: 10.1002/rcm.2132. [DOI] [PubMed] [Google Scholar]
  38. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10:1093–5. doi: 10.1023/a:1018943613122. [DOI] [PubMed] [Google Scholar]
  39. Nováková L, Vlcková H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal Chim Acta. 2009;656:8–35. doi: 10.1016/j.aca.2009.10.004. [DOI] [PubMed] [Google Scholar]
  40. Serrano M, Salva M, Gallego M. Micro liquid-liquid extraction combined with large-volume injection gas chromatography-mass spectrometry for the determination of haloacetaldehydes in treated water. J Chromatogr A. 2011;1218:8295–302. doi: 10.1016/j.chroma.2011.09.048. [DOI] [PubMed] [Google Scholar]
  41. Wang L, Sun Y, Du FF, Niu W, Lu T, Kan JM, et al. 'LC-electrolyte effects' improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting drug discovery pharmacokinetic study. Rapid Commun Mass Spectrom. 2007;21:2573–84. doi: 10.1002/rcm.3129. [DOI] [PubMed] [Google Scholar]

Articles from Acta Pharmacologica Sinica are provided here courtesy of Nature Publishing Group

RESOURCES